Date Hour Room Track
04th December,2018 4:30-6:00 pm Track 3

When creating a biotech start-up, different routes can be taken: The virtual biotech model, the technology platform model, the one single asset company… How do those initial choices influence the exit scenario of the company?

Speakers
Peter Leonardi - OmniCyte
George Hoffmann - Network Immunology
Rodolphe Besserve - Société Générale Corporate Investments and Banking
Lucie Ellis - Pharma Intelligence | Informa
Mark Krul - AGLAIA BIOMEDICAL VENTURES

Continue your tour